A Trial Aiming to Assess the Safety and Activity of the Combination of Cabozantinib Plus Lanreotide in GEP and NET
Clinical trial NCT04427787 · UNKNOWN
Trial details
- NCT number
- NCT04427787
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-20
- Primary completion
- 2023-11-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.